Allergic Mediator Antagonists

Allergic mediator antagonists are APIs designed to block or modulate biochemical mediators responsible for allergic reactions, including leukotrienes, prostaglandins, platelet-activating factor, and cytokines. These agents inhibit downstream inflammatory pathways, reducing bronchoconstriction, vascular permeability, tissue swelling, and pruritus. They are widely used for asthma, allergic rhinitis, atopic dermatitis, urticaria, and food-related allergic responses. Common APIs include leukotriene receptor antagonists, 5-lipoxygenase inhibitors, mast cell stabilizers, and biologics targeting specific immune modulators. Their targeted pharmacological action improves symptom control, reduces exacerbation frequency, and minimizes reliance on systemic corticosteroids. Allergic mediator antagonists play an essential role in long-term allergy management and personalized immunotherapy.